Overview

A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the Bioavailability for GV-971 capsules of 150 mg, 300mg, and 450mg after administration of single oral doses of 900mg in healthy Male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Greenvalley Pharmaceutical Co., Ltd.